Home/Filings/4/0001179110-18-011284
4//SEC Filing

Cunnane Deirdre A. 4

Accession 0001179110-18-011284

CIK 0001454789other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 4:15 PM ET

Size

5.5 KB

Accession

0001179110-18-011284

Insider Transaction Report

Form 4
Period: 2018-09-07
Cunnane Deirdre A.
SVP, General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2018-09-07+150,000150,000 total
    Exercise: $0.71Exp: 2028-09-06Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]This option was granted on September 7, 2018 and is subject to vesting over a two year period, with 50% of the shares vesting on the first anniversary of September 7, 2018 and the remainder vesting over the ensuing year at a rate of 4.1667% per month.

Issuer

CATABASIS PHARMACEUTICALS INC

CIK 0001454789

Entity typeother

Related Parties

1
  • filerCIK 0001666942

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:15 PM ET
Size
5.5 KB